Approval · Notice of Compliance 34787 · 2025
ENGEMYCIN DD: Notice of Compliance 34787
Issued February 5, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34787
- Date
- February 5, 2025
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Data in support the reactivation of the DIN
- Canadian reference product
- OXYMYCINE LP
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENGEMYCIN DD | 02304236 | Marketed |
Medicinal ingredients
- OXYTETRACYCLINE HCL 100 MG per ML